Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells
Chen Peng(China Agricultural University), Bernard Moss(National Institute of Allergy and Infectious Diseases)
Cited by 49
Related Papers
Poxvirus DNA Replication
|Cold Spring Harbor Perspectives in Biology|2013|377
Poxvirus Cell Entry: How Many Proteins Does it Take?
|Viruses|2012|262
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
|The Journal of Infectious Diseases|2011|177
Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
|The Journal of Infectious Diseases|2014|84
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
|The Journal of Infectious Diseases|2018|45